A year after Baby KJ became the first person to receive a personalized CRISPR base-editing therapy for a lethal genetic disorder, he is thriving and has avoided a liver transplant. His case, enabled ...
It took years and major changes in how gene therapies are delivered for the field to recover. And now, 27 years after ...
IDT played a pivotal role in manufacturing the personalized gene editing therapy given to baby KJ Muldoon to treat his rare ...
Creating standardized building blocks, including gene editing proteins, guide RNAs, donor templates, and delivery vehicles, ...
Aging research has entered a transformative era with the advent of genome editing technologies, particularly CRISPR-Cas9, which enable precise and efficient ...
In late April 2026, analysts highlighted expectations for higher year-over-year earnings and revenue at CRISPR Therapeutics ahead of its March-quarter report, alongside strong launch metrics for ...
A CRISPR Therapy Just Cured A Disease From Inside The Body For The First Time. The Gene-Editing Era Officially Started Monday ...
Researchers have used saturation genome editing to test every variant in the non coding gene RNU4 2, revealing new pathogenic ...
Two papers published in The New England Journal of Medicine highlight the potential of gene editing for treatment of sickle ...
Posters detail large gene insertion and epigenetic editing capabilities, expanding ElevateBio’s gene editing toolbox ...
A phase 3 trial of Intellia Therapeutics’ in vivo gene-editing therapy lonvoguran ziclumeran (lonvo-z) has hit its primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results